FiDUS Power offers availability of the NEVO range of smallest in its class modular configurable power supplies including medical variants. Both sizes of the power supplies are provided with the latest in medical safety approvals for safety EN/IEC/ANSI 60601-1 and EMC immunity EN60601-1-2 4th edition and comply with EN55022 level B EMC Standards. Suitable for applications including medical and diagnostic devices, medical robotics, dialysis/peristaltic pumps, benchtop laboratory and analysis equipment, laser power, operating theatre lighting, incubators, display applications, telecommunications and retrofit of legacy power multi-output supplies.
Two powers are available: the 600W output NEVO+600 (5" x 3" x 1.61") and the NEVO+1200 (6" x 6" x 1.61") which provides an impressive 1200W of output power. The power dense units fit conveniently into a 1U enclosure with robust enclosed mechanics. Both models provide ITE and medical variants and feature analogue current and voltage programming, analogue current output signal, 5V bias supply (one per card, one per 600W chassis and two on the 1200 chassis), global/local inhibit, AC OK and DC OK power good signals.
Accurate current sharing over multiple modules is a standard feature allowing them to be employed in the most demanding applications where a large output current of up to 100A is needed. Outputs can also be readily configured in series to support applications needing high voltages of up to 240VDC. The units employ an integrated fan (low noise option for sound-sensitive applications) with intelligent control which offers thermal versatility and orientation flexibility to best suit the end product.
“Our new NEVO modular, configurable, compact power supplies truly offer unrivalled performance and flexibility”, comments Mark Gibbons, engineering manager at FiDUS Power. “The front ends and the cards all have their own approvals, so unlike some of our competitors changes can be made on the fly by the customer and samples can be made and delivered in less than a week from the lab in Aldermaston.”
09-07-2020 | Power